Treatment for Takayasu Arteritis with Pulmonary Artery Issues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of medical treatment and percutaneous transluminal pulmonary angioplasty on patients with Takayasu arteritis complicated by pulmonary artery involvement. It aims to assess the efficacy of FAPI imaging in predicting disease activity and treatment outcomes. Patients will undergo baseline evaluations using FAPI and FDG to determine the severity of their condition and the potential effectiveness of the interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients diagnosed with Takayasu arteries with pulmonary arteries involvement

Exclusion Criteria:

* Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis

Where it's running

• Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
  Beijing, China, China Recruiting

Study contacts

• Principal investigator: zhihong Liu, doctor — Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
• Study coordinator: Zhihong Liu, doctor
• Email: zhihongliufuwai@163.com
• Phone: 86-010-88396589

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Takayasu arteritis that affects the lung arteries: symptoms and long-term outlook

  This project will follow people with Takayasu arteritis involving the pulmonary arteries to see what their symptoms, treatments, and long-term outcomes are.

  Recruiting China-Japan Friendship Hospital · Beijing, Beijing Municipality · NCT07184814

• Sleep problems in PAH patients: how sleep breathing relates to PAH outcomes

  This study tests how sleep-disordered breathing and nocturnal oxygen changes relate to outcomes in adults with pulmonary arterial hypertension.

  Recruiting Chinese Pulmonary Vascular Disease Research Group · Beijing · NCT07852403

• Registry of patients with pulmonary hypertension receiving targeted therapy

  This study is collecting information from over 5,000 patients in China with pulmonary hypertension who are using targeted therapies to see how well these treatments work and how the disease progresses over three years.

  Recruiting Chinese Pulmonary Vascular Disease Research Group · Beijing · NCT06135909

• Investigating the link between obstructive sleep apnea and pulmonary hypertension

  This study looks at how common sleep apnea is in adults with pulmonary hypertension and how it affects their health.

  Recruiting Chinese Pulmonary Vascular Disease Research Group · Beijing · NCT05595200

• Using artificial intelligence to evaluate pulmonary hypertension

  This study is testing if using artificial intelligence with different medical tests can help doctors find pulmonary hypertension earlier and more accurately in patients.

  Recruiting Chinese Pulmonary Vascular Disease Research Group · Beijing, Beijing Municipality · NCT05566002

• Evaluating balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension in China

  This study is testing whether balloon pulmonary angioplasty can safely help people with chronic thromboembolic pulmonary hypertension who can't have surgery or still have symptoms after surgery.

  Recruiting at 2 sites Chinese Pulmonary Vascular Disease Research Group · Beijing and 1 other locations · NCT04206852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.